Funding keeps the wheels going round and round!
Vision Bus Aotearoa (VBA) secured renewed funding from the Buchanan Charitable Foundation, enabling continued mobile eyecare service delivery to underserved
Susanne Bradley3 min read
Advertisement
Vision Bus Aotearoa (VBA) secured renewed funding from the Buchanan Charitable Foundation, enabling continued mobile eyecare service delivery to underserved
Meryl Streep, Emily Blunt, and Anne Hathaway wore specific designer sunglasses from Etnia Barcelona, Emmanuelle Khanh, and Khaite x Oliver Peoples at a fashion photocall for The Devil Wears Prada 2.
Japanese research suggests alcohol consumption may be linked to faster presbyopia progression in men. A study of 6,258 people found male drinkers reached
Eye Health Aotearoa (EHA) is hosting a Parliamentary Friends of Eye Health event on 21 July to elevate vision care as
A University of Auckland analysis suggests allocating 1.2% of Aotearoa’s health budget to community eyecare could fund 2.
Optometry Australia will unify into a single national entity after overwhelming member support across all State Divisions. This move aims to create a stronger peak body with expert
Hoya Vision Care reports first-year trial data for Miyosmart iQ spectacle lenses, showing "some reversal" in older children and
Ocular melanoma, including choroidal, iris, and conjunctival types, is rare but serious. Early detection by optometrists and ophthalmologists through
Auckland ophthalmologist Dr Divya Perumal was targeted by a deepfake video promoting an unregulated ‘sight-saving’ product. The AI-generated
We’re now reviewing your feedback and look forward to sharing key insights, along with our next steps and the impact of our community donation, in the coming weeks. The Prezzy Card draw is taking place on 5 June, so keep an eye on your inbox!
Unmistakably Albert I’mStein, stylish OhChoco is part of the Polish brand’s signature Cocktail series. OhChoco is a funky square shape available in six colour combinations and is effortlessly versatil
Revisyon's developer responds to NZ eyecare professionals’ concerns about its safety and effectiveness